51. Cross‐sectional amyloid and tau PET in cognitively normal older adults enrolled in the U.S. POINTER lifestyle intervention trial. (December 2021) Authors: Harrison, Theresa M.; Vemuri, Prashanthi; Koeppe, Robert A.; Lockhart, Samuel N.; Jung, Youngkyoo; Borowski, Bret J.; Murphy, Alice; Ward, Tyler; Gordineer, Leslie; Woolard, Nancy; Espeland, Mark A.; Harvey, Danielle J.; Jagust, William J.; Lovato, Laura; Toga, Arthur W.; Masdeu, Joseph C.; Oh, H... Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
52. CSF biomarker variability in the Alzheimer's Association quality control program. Issue 3 (1st May 2013) Authors: Mattsson, Niklas; Andreasson, Ulf; Persson, Staffan; Carrillo, Maria C.; Collins, Steven; Chalbot, Sonia; Cutler, Neal; Dufour‐Rainfray, Diane; Fagan, Anne M.; Heegaard, Niels H.H.; Robin Hsiung, Ging‐Yuek; Hyman, Bradley; Iqbal, Khalid; Lachno, D. Richard; Lleó, Alberto; Lewczuk, Piotr; Molinuev... Journal: Alzheimer's & dementia Issue: Volume 9:Issue 3(2013) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
53. Current directions in tau research: Highlights from Tau 2020. Issue 5 (28th September 2021) Authors: Sexton, Claire; Snyder, Heather; Beher, Dirk; Boxer, Adam L.; Brannelly, Pat; Brion, Jean‐Pierre; Buée, Luc; Cacace, Angela M.; Chételat, Gaël; Citron, Martin; DeVos, Sarah L.; Diaz, Kristophe; Feldman, Howard H.; Frost, Bess; Goate, Alison M.; Gold, Michael; Hyman, Bradley; Johnson, Keith; Karch... Journal: Alzheimer's & dementia Issue: Volume 18:Issue 5(2022) Page Start: 988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
54. Current understanding of AD pathophysiology and impact of amyloid beta–targeted treatments on biomarkers and clinical endpoints. Issue 8 (10th August 2022) Authors: Petersen, Ronald C.; Graf, Ana; Carrillo, Maria C.; Weber, Christopher J. Journal: Alzheimer's & dementia Issue: Volume 18:Issue 8(2022) Page Start: 1586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
55. Current understanding of AD pathophysiology and impact of amyloid‐beta targeted treatments on biomarkers and clinical endpoints. Issue 1 (20th October 2022) Authors: Petersen, Ronald C.; Graf, Ana; Carrillo, Maria C.; Weber, Christopher J. Journal: Alzheimer's & dementia Issue: Volume 8:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
56. Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force. Issue 4 (1st July 2013) Authors: Vellas, Bruno; Carrillo, Maria C.; Sampaio, Cristina; Brashear, H. Robert; Siemers, Eric; Hampel, Harald; Schneider, Lon S.; Weiner, Michael; Doody, Rachelle; Khachaturian, Zaven; Cedarbaum, Jesse; Grundman, Michael; Broich, Karl; Giacobini, Ezio; Dubois, Bruno; Sperling, Reisa; Wilcock, Gordon K... Journal: Alzheimer's & dementia Issue: Volume 9:Issue 4(2013) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
57. Developing novel blood‐based biomarkers for Alzheimer's disease. Issue 1 (1st January 2014) Authors: Snyder, Heather M.; Carrillo, Maria C.; Grodstein, Francine; Henriksen, Kim; Jeromin, Andreas; Lovestone, Simon; Mielke, Michelle M.; O'Bryant, Sid; Sarasa, Manual; Sj⊘gren, Magnus; Soares, Holly; Teeling, Jessica; Trushina, Eugenia; Ward, Malcolm; West, Tim; Bain, Lisa J.; Shineman, Diana W.; We... Journal: Alzheimer's & dementia Issue: Volume 10:Issue 1(2014) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
58. Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials. Issue 1 (23rd May 2018) Authors: Gold, Michael; Amatniek, Joan; Carrillo, Maria C.; Cedarbaum, Jesse M.; Hendrix, James A.; Miller, Bradley B.; Robillard, Julie M.; Rice, J. Jeremy; Soares, Holly; Tome, Maria B.; Tarnanas, Ioannis; Vargas, Gabriel; Bain, Lisa J.; Czaja, Sara J. Journal: Alzheimer's & dementia Issue: Volume 4:Issue 1(2018) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
59. DT‐02‐01: APPROPRIATE USE CRITERIA FOR LUMBAR PUNCTURE AND CEREBROSPINAL FLUID TESTING IN THE DIAGNOSIS OF ALZHEIMER'S DISEASE. (1st July 2006) Authors: Shaw, Leslie M.; Arias, Jalayne J.; Blennow, Kaj; Galasko, Doug R.; Molinuevo, José Luis; Salloway, Stephen; Schindler, Suzanne E.; Carrillo, Maria C.; Hendrix, James; Ross, April; Illes, Judit; Ramus, Courtney; Fifer, Sheila Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7(2018)Part 31 Page Start: P1668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
60. Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: A new approach. (1st February 2013) Authors: Posner, Holly B.; Cano, Stefan; Carrillo, Maria C.; Selnes, Ola; Stern, Yaakov; Thomas, Ronald G.; Zajicek, John; Hobart, Jeremy Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 1(2013) Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗